Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Performance of three dimensional right ventricular evaluation and right ventricular strain in sickle cell disease patients
Session:
Sessão de Posters 05 - Ecocardiografia
Speaker:
Ana Raquel Carvalho Santos
Congress:
CPC 2024
Topic:
B. Imaging
Theme:
03. Imaging
Subtheme:
03.1 Echocardiography
Session Type:
Cartazes
FP Number:
---
Authors:
Ana Raquel Carvalho Santos; Inês Vieira; Isabel Cardoso; Christopher Saunders; Madalena Silva; Tania Mano; Vera Ferreira; Pedro Rio; Ana Teresa Timoteo; Ana Galrinho; Patricia Ribeiro; Rui Cruz Ferreira
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">Echocardiography (TTE) is recommended for routine follow-up of all sickle cell disease (SCD) patients (pts) for assessment of possible cardiovascular (CV) complications. Cardiac remodelling occurs in these pts due to a high-output state. Additionally, pulmonary hypertension may develop due to pulmonary vasculopathy. TTE with focus on right ventricular evaluation is essential for detecting SCD cardiomyopathy. </span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">Aim: Evaluate the performance of 3D right ventricular evaluation and right ventricular strain in pts with SCD. </span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">Methods: A prospective, single centre analysis was made including pts with sickle cell disease referred for evaluation in Hemoglobinopathies clinic. TTE was performed as part of usual follow up. Special attention was given to 3D right ventricular image acquisition and right ventricular strain. Data were collected on population characteristics and TTE measurements. When testing hypothesis, Mann-Whitney test was performed. A p value of 0.05 was considered statistically significant.</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">Results:</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">From September to November 2023, TTE evaluation was acquired in 22 pts, median age 30 (22-40) years. The majority of pts were female (63.6%), with 45.5% having a vaso-occlusive crisis in the last year and 13.6% needing regular transfusion therapy. Regarding CV disease, 4.5% had hypertension, 4.5% atrial fibrillation, 27.3% kidney disease and 22.5% history of stroke. Table 1 specifies TTE measurements of included pts. Regarding altered parameters, 9% had septal hypertrophy, 59% large left atrium, 9% large right atrium, 41% large left ventricular (LV) volumes, 9% LV ejection fraction bellow 54%, 23% cardiac index above 4.5L/min/m2, 59% LV longitudinal strain below -19%, 4.5% pulmonary systolic artery pressure above 30mmHg and tricuspid regurgitation velocity above 2.5cm/s, 18% E/A ratio above 2 and, 45% 3D right ventricular ejection fraction (RVEF) bellow 44% and decreased right ventricular free wall strain. Tricuspid s’ and tricuspid annular plane systolic excursion were normal, even when RVEF was decreased. Additionally, when comparing those two parameters and 3D RVEF, there was no association. Although, pulmonary acceleration time was lower in pts with lower 3D RVEF (134ms Vs 159ms, p= 0.036). </span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">Conclusion:</span></span></p> <p><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif">Right ventricular evaluation is one of the major focuses when performing TTE in SCD pts. As showed in our analysis commonly used parameters may not be sufficient to detect discrete alterations. 3D RVEF may have a role in the routinely evaluation of these pts.</span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site